Percutaneous Microwave Tumor Ablation Is Safe in Patients with Cardiovascular Implantable Electronic Devices: A Single-Institutional Retrospective Review

J Vasc Interv Radiol. 2019 Mar;30(3):396-400. doi: 10.1016/j.jvir.2018.12.001.

Abstract

The risk of electromagnetic interference between microwave (MW) ablation and cardiac implantable electronic devices (CIEDs), ie, pacemakers and defibrillators, has not been fully evaluated. Fourteen MW ablations (kidney, n = 8; liver, n = 5; lung, n = 1) were performed in 13 patients with CIEDs in normal operating mode. Electrocardiography tracings, cardiovascular complications, tumor size, tumor-to-CIED distance, and tumor-to-device lead distance were recorded. Mean tumor size was 2.9 cm, mean tumor-to-CIED distance was 26.4 cm (range, 9-30 cm), and mean tumor-to-lead distance was 12.1 cm (range, 3.5-20 cm). No device-based cardiovascular complications or class C or higher complications per Society of Interventional Radiology criteria were identified. MW ablation appears to be safe in select patients with CIEDs.

MeSH terms

  • Ablation Techniques* / adverse effects
  • Adult
  • Aged
  • Aged, 80 and over
  • Databases, Factual
  • Defibrillators, Implantable* / adverse effects
  • Electrocardiography
  • Electromagnetic Fields
  • Equipment Failure
  • Female
  • Humans
  • Male
  • Microwaves / adverse effects
  • Microwaves / therapeutic use*
  • Middle Aged
  • Neoplasms / pathology
  • Neoplasms / surgery*
  • Pacemaker, Artificial* / adverse effects
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome
  • Tumor Burden
  • Wisconsin